inflammatory disease therapy (UCB)

N/A

Report date: 2025/03/20 15:31:15

Base Information

Drug Nameinflammatory disease therapy (UCB)
Drug Alias Nameinflammatory disease therapy (Five Prime)
ClassificationBiologics > Protein drugs > Recombinant polypeptide
Mechanisms of ActionUpdating
TargetsUpdating
Therapy Area/IndicationsInflammation
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesFive Prime Therapeutics Inc
China Registration ClassN/A

Develop Information

Active CompaniesUcb Sa
Inactive CompaniesFive Prime Therapeutics Inc
Active IndicationsInflammation
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A